| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Manganese | 26 | 2024 | 87 | 9.890 |
Why?
|
| Astrocytes | 31 | 2023 | 255 | 9.570 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 13 | 2021 | 38 | 6.950 |
Why?
|
| Manganese Poisoning | 11 | 2023 | 22 | 5.020 |
Why?
|
| YY1 Transcription Factor | 7 | 2022 | 18 | 4.640 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 7 | 2020 | 16 | 3.670 |
Why?
|
| Up-Regulation | 9 | 2024 | 513 | 3.120 |
Why?
|
| Amino Acid Transport System X-AG | 5 | 2017 | 11 | 2.120 |
Why?
|
| Repressor Proteins | 4 | 2022 | 249 | 2.050 |
Why?
|
| Parkinson Disease | 6 | 2023 | 178 | 1.900 |
Why?
|
| Brain | 9 | 2022 | 1346 | 1.880 |
Why?
|
| Estradiol | 3 | 2024 | 262 | 1.720 |
Why?
|
| Transforming Growth Factor alpha | 5 | 2017 | 22 | 1.690 |
Why?
|
| Microglia | 4 | 2024 | 166 | 1.680 |
Why?
|
| Animals | 46 | 2024 | 15081 | 1.470 |
Why?
|
| Dopamine | 6 | 2023 | 245 | 1.470 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 1015 | 1.360 |
Why?
|
| Oxidative Stress | 10 | 2024 | 938 | 1.330 |
Why?
|
| Valproic Acid | 2 | 2018 | 16 | 1.230 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 578 | 1.210 |
Why?
|
| NF-kappa B | 7 | 2017 | 339 | 1.210 |
Why?
|
| Cells, Cultured | 17 | 2021 | 1518 | 1.190 |
Why?
|
| Neuroprotective Agents | 5 | 2024 | 245 | 1.170 |
Why?
|
| Tamoxifen | 3 | 2017 | 65 | 1.140 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 71 | 1.100 |
Why?
|
| Neurotoxins | 3 | 2021 | 57 | 1.100 |
Why?
|
| Neurotoxicity Syndromes | 3 | 2021 | 35 | 1.000 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2020 | 78 | 0.950 |
Why?
|
| Sp1 Transcription Factor | 1 | 2024 | 48 | 0.950 |
Why?
|
| Yin-Yang | 1 | 2022 | 2 | 0.880 |
Why?
|
| I-kappa B Kinase | 2 | 2021 | 44 | 0.870 |
Why?
|
| Mice | 12 | 2024 | 5913 | 0.870 |
Why?
|
| Parkinsonian Disorders | 1 | 2023 | 37 | 0.870 |
Why?
|
| Rats | 20 | 2016 | 3483 | 0.840 |
Why?
|
| alpha-Synuclein | 2 | 2020 | 52 | 0.820 |
Why?
|
| Reactive Oxygen Species | 3 | 2021 | 461 | 0.810 |
Why?
|
| Cation Transport Proteins | 2 | 2021 | 34 | 0.800 |
Why?
|
| Substantia Nigra | 2 | 2020 | 44 | 0.800 |
Why?
|
| Estrogens | 2 | 2014 | 202 | 0.790 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2016 | 1618 | 0.780 |
Why?
|
| Inflammation | 3 | 2022 | 618 | 0.760 |
Why?
|
| Lysophosphatidylcholines | 3 | 2005 | 22 | 0.750 |
Why?
|
| Motor Activity | 3 | 2017 | 418 | 0.740 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2014 | 86 | 0.720 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 173 | 0.710 |
Why?
|
| Selective Estrogen Receptor Modulators | 3 | 2014 | 32 | 0.690 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2024 | 356 | 0.670 |
Why?
|
| Apoptosis | 4 | 2022 | 1398 | 0.650 |
Why?
|
| Cell Line | 6 | 2024 | 1354 | 0.650 |
Why?
|
| Promoter Regions, Genetic | 6 | 2021 | 515 | 0.650 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 219 | 0.640 |
Why?
|
| Signal Transduction | 9 | 2017 | 1908 | 0.620 |
Why?
|
| Humans | 27 | 2024 | 37093 | 0.620 |
Why?
|
| Caprylates | 1 | 2017 | 11 | 0.600 |
Why?
|
| Butyric Acid | 1 | 2017 | 18 | 0.600 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 54 | 0.550 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2020 | 77 | 0.540 |
Why?
|
| Glutamic Acid | 5 | 2021 | 128 | 0.530 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 98 | 0.440 |
Why?
|
| Histone Deacetylases | 3 | 2020 | 56 | 0.420 |
Why?
|
| Oncogene Proteins | 1 | 2011 | 21 | 0.410 |
Why?
|
| Prostaglandin D2 | 1 | 2011 | 27 | 0.400 |
Why?
|
| Mutation | 3 | 2023 | 1095 | 0.400 |
Why?
|
| Chlorides | 4 | 2020 | 56 | 0.400 |
Why?
|
| Lewy Bodies | 2 | 2023 | 30 | 0.390 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 187 | 0.370 |
Why?
|
| S-Adenosylmethionine | 3 | 2005 | 38 | 0.360 |
Why?
|
| Base Sequence | 3 | 2020 | 997 | 0.360 |
Why?
|
| Protein Binding | 4 | 2020 | 972 | 0.330 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 2 | 2005 | 6 | 0.330 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2006 | 99 | 0.330 |
Why?
|
| Locomotion | 2 | 2020 | 97 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 152 | 0.310 |
Why?
|
| RNA, Messenger | 3 | 2020 | 1207 | 0.300 |
Why?
|
| Phospholipids | 2 | 2005 | 70 | 0.300 |
Why?
|
| Dopamine Antagonists | 2 | 2004 | 44 | 0.300 |
Why?
|
| Phosphorylation | 4 | 2021 | 928 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 1609 | 0.280 |
Why?
|
| Phencyclidine | 1 | 2006 | 19 | 0.280 |
Why?
|
| Neurotransmitter Agents | 2 | 2020 | 63 | 0.280 |
Why?
|
| Glutamine | 4 | 2019 | 40 | 0.270 |
Why?
|
| Transcriptional Activation | 2 | 2020 | 172 | 0.270 |
Why?
|
| MPTP Poisoning | 1 | 2005 | 11 | 0.260 |
Why?
|
| Manganese Compounds | 4 | 2020 | 16 | 0.260 |
Why?
|
| Homocysteine | 1 | 2005 | 19 | 0.260 |
Why?
|
| Estrogen Receptor alpha | 2 | 2017 | 111 | 0.260 |
Why?
|
| Neurons | 4 | 2019 | 1175 | 0.260 |
Why?
|
| Membrane Transport Proteins | 2 | 2015 | 95 | 0.260 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 137 | 0.260 |
Why?
|
| Nerve Degeneration | 3 | 2021 | 107 | 0.250 |
Why?
|
| Tyrosine | 1 | 2005 | 118 | 0.250 |
Why?
|
| Mammals | 2 | 2022 | 105 | 0.250 |
Why?
|
| Response Elements | 2 | 2015 | 56 | 0.240 |
Why?
|
| Transcription Factors | 3 | 2020 | 681 | 0.240 |
Why?
|
| Neurodegenerative Diseases | 3 | 2021 | 131 | 0.240 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 290 | 0.240 |
Why?
|
| Receptors, Dopamine | 1 | 2004 | 25 | 0.230 |
Why?
|
| Carrier Proteins | 2 | 2020 | 305 | 0.230 |
Why?
|
| Glutathione | 2 | 2017 | 179 | 0.230 |
Why?
|
| Metals, Heavy | 1 | 2024 | 60 | 0.230 |
Why?
|
| Behavior, Animal | 1 | 2005 | 314 | 0.220 |
Why?
|
| Cell Differentiation | 1 | 2006 | 587 | 0.210 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 211 | 0.210 |
Why?
|
| Blotting, Western | 5 | 2012 | 859 | 0.210 |
Why?
|
| Autophagy | 1 | 2023 | 116 | 0.210 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2021 | 49 | 0.200 |
Why?
|
| Gene Deletion | 1 | 2022 | 166 | 0.200 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 409 | 0.200 |
Why?
|
| Serine | 1 | 2021 | 75 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 360 | 0.200 |
Why?
|
| Retina | 1 | 2024 | 280 | 0.200 |
Why?
|
| Male | 7 | 2020 | 20025 | 0.200 |
Why?
|
| Parenteral Nutrition | 1 | 2021 | 13 | 0.190 |
Why?
|
| Cell Survival | 3 | 2017 | 864 | 0.190 |
Why?
|
| Transferrin | 1 | 2020 | 40 | 0.190 |
Why?
|
| Methylation | 3 | 2005 | 113 | 0.190 |
Why?
|
| Calcium Channels | 1 | 2020 | 76 | 0.180 |
Why?
|
| Brain Chemistry | 3 | 2005 | 140 | 0.180 |
Why?
|
| CREB-Binding Protein | 1 | 2020 | 13 | 0.180 |
Why?
|
| Models, Biological | 2 | 2014 | 677 | 0.180 |
Why?
|
| Heme Oxygenase-1 | 1 | 2020 | 51 | 0.180 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 70 | 0.170 |
Why?
|
| Drug Interactions | 2 | 2012 | 141 | 0.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 93 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2006 | 421 | 0.170 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1180 | 0.160 |
Why?
|
| Down-Regulation | 1 | 2020 | 435 | 0.160 |
Why?
|
| Anticonvulsants | 1 | 2018 | 34 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 269 | 0.160 |
Why?
|
| Malondialdehyde | 1 | 2017 | 41 | 0.150 |
Why?
|
| Ovariectomy | 1 | 2017 | 105 | 0.150 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2017 | 77 | 0.150 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 14 | 0.150 |
Why?
|
| Mice, Knockout | 1 | 2020 | 933 | 0.150 |
Why?
|
| Catalase | 1 | 2017 | 109 | 0.150 |
Why?
|
| Cerebellum | 1 | 2017 | 73 | 0.150 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 893 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 617 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2011 | 550 | 0.130 |
Why?
|
| Quinazolines | 1 | 2016 | 33 | 0.130 |
Why?
|
| PC12 Cells | 2 | 2006 | 93 | 0.130 |
Why?
|
| Tritium | 2 | 2006 | 51 | 0.130 |
Why?
|
| Dizocilpine Maleate | 2 | 2006 | 48 | 0.130 |
Why?
|
| Protein Transport | 2 | 2015 | 302 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 37 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 114 | 0.130 |
Why?
|
| Cytoprotection | 2 | 2011 | 36 | 0.130 |
Why?
|
| Cytokines | 1 | 2019 | 602 | 0.130 |
Why?
|
| Gene Expression | 1 | 2018 | 674 | 0.130 |
Why?
|
| Injections, Intraventricular | 2 | 2005 | 64 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 1039 | 0.120 |
Why?
|
| Estrogen Receptor beta | 1 | 2014 | 40 | 0.120 |
Why?
|
| Protein Kinase C | 2 | 2012 | 120 | 0.120 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 905 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 40 | 0.120 |
Why?
|
| Cell Extracts | 1 | 2013 | 16 | 0.120 |
Why?
|
| Homeostasis | 1 | 2015 | 188 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 133 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 76 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 73 | 0.120 |
Why?
|
| Animals, Newborn | 5 | 2014 | 343 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 136 | 0.110 |
Why?
|
| src-Family Kinases | 1 | 2013 | 46 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 76 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 173 | 0.110 |
Why?
|
| Amino Acid Transport System ASC | 2 | 2011 | 3 | 0.110 |
Why?
|
| Amino Acid Transport Systems, Neutral | 2 | 2011 | 4 | 0.110 |
Why?
|
| Kinetics | 2 | 2005 | 708 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 169 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 156 | 0.110 |
Why?
|
| Chemokines | 1 | 2012 | 97 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2012 | 100 | 0.100 |
Why?
|
| Morpholines | 1 | 2011 | 69 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 286 | 0.100 |
Why?
|
| Binding Sites | 1 | 2013 | 651 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 123 | 0.100 |
Why?
|
| Chromones | 1 | 2011 | 54 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2012 | 151 | 0.100 |
Why?
|
| Mercury Poisoning, Nervous System | 1 | 2011 | 2 | 0.100 |
Why?
|
| Methylmercury Compounds | 1 | 2011 | 4 | 0.100 |
Why?
|
| Organoselenium Compounds | 1 | 2011 | 10 | 0.100 |
Why?
|
| Azoles | 1 | 2011 | 14 | 0.100 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2010 | 5 | 0.100 |
Why?
|
| Dipeptides | 1 | 2010 | 32 | 0.090 |
Why?
|
| Female | 3 | 2020 | 20969 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 448 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 213 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 312 | 0.080 |
Why?
|
| Environmental Pollutants | 1 | 2011 | 179 | 0.080 |
Why?
|
| Antioxidants | 1 | 2011 | 416 | 0.070 |
Why?
|
| Biogenic Amines | 1 | 2006 | 11 | 0.070 |
Why?
|
| Nerve Growth Factor | 1 | 2006 | 30 | 0.070 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 57 | 0.070 |
Why?
|
| Neurites | 1 | 2006 | 39 | 0.070 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2005 | 9 | 0.070 |
Why?
|
| Phosphatidylethanolamines | 1 | 2005 | 27 | 0.070 |
Why?
|
| Catheterization | 1 | 2005 | 24 | 0.070 |
Why?
|
| Neostriatum | 1 | 2005 | 26 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 2005 | 47 | 0.060 |
Why?
|
| Hypokinesia | 1 | 2005 | 3 | 0.060 |
Why?
|
| Quinacrine | 1 | 2005 | 5 | 0.060 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2005 | 30 | 0.060 |
Why?
|
| Chromatography, Thin Layer | 1 | 2005 | 37 | 0.060 |
Why?
|
| Adenosine | 1 | 2005 | 59 | 0.060 |
Why?
|
| Gliosis | 1 | 2004 | 24 | 0.060 |
Why?
|
| Ibuprofen | 1 | 2004 | 32 | 0.060 |
Why?
|
| Apigenin | 1 | 2004 | 13 | 0.060 |
Why?
|
| Pyridinium Compounds | 1 | 2005 | 27 | 0.060 |
Why?
|
| Mazindol | 1 | 2004 | 4 | 0.060 |
Why?
|
| Methyltransferases | 1 | 2005 | 58 | 0.060 |
Why?
|
| Serotonin | 1 | 2005 | 123 | 0.060 |
Why?
|
| Radioligand Assay | 1 | 2004 | 66 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2004 | 111 | 0.060 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2004 | 50 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2024 | 29 | 0.060 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2004 | 40 | 0.060 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2004 | 73 | 0.060 |
Why?
|
| Benzazepines | 1 | 2004 | 32 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2004 | 207 | 0.060 |
Why?
|
| Benzamides | 1 | 2004 | 78 | 0.060 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2004 | 77 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 2004 | 104 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 149 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2012 | 61 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2004 | 381 | 0.050 |
Why?
|
| Liver | 1 | 2005 | 479 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 131 | 0.050 |
Why?
|
| Metabolome | 1 | 2021 | 53 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2014 | 366 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 53 | 0.050 |
Why?
|
| Trace Elements | 1 | 2021 | 30 | 0.050 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2011 | 11 | 0.050 |
Why?
|
| Risk | 1 | 2021 | 267 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 146 | 0.050 |
Why?
|
| Time Factors | 2 | 2014 | 1742 | 0.040 |
Why?
|
| Thiazolidines | 1 | 2014 | 5 | 0.030 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2014 | 7 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2014 | 53 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 59 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 155 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2014 | 444 | 0.030 |
Why?
|
| Child | 1 | 2021 | 3131 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2012 | 8 | 0.030 |
Why?
|
| Protein Kinase C-delta | 1 | 2012 | 18 | 0.030 |
Why?
|
| Protein Kinase C-alpha | 1 | 2012 | 10 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 40 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 2012 | 58 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 42 | 0.030 |
Why?
|
| Cytosol | 1 | 2012 | 93 | 0.030 |
Why?
|
| Caspases | 1 | 2012 | 147 | 0.030 |
Why?
|
| Lysosomes | 1 | 2012 | 91 | 0.030 |
Why?
|
| Biotinylation | 1 | 2011 | 11 | 0.030 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2011 | 10 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 502 | 0.020 |
Why?
|
| Endocytosis | 1 | 2012 | 113 | 0.020 |
Why?
|
| Isoindoles | 1 | 2011 | 18 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2011 | 78 | 0.020 |
Why?
|
| Hepatic Encephalopathy | 1 | 2010 | 11 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 84 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 75 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 207 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 252 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2011 | 517 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 487 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 11712 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2004 | 26 | 0.020 |
Why?
|
| Propidium | 1 | 2004 | 19 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2004 | 22 | 0.020 |
Why?
|
| G2 Phase | 1 | 2004 | 29 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 133 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 121 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 326 | 0.010 |
Why?
|
| DNA Damage | 1 | 2004 | 352 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2004 | 1198 | 0.010 |
Why?
|